Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CMT-dos > DM I > Flashcards

DM I Flashcards

1
Q

Pancreas

endocrine function

A

Islet of Langerhans cells – secretes hormones and hormone-like messengers

Insulin
Secreted by beta cell in response to rising concentrations of glucose

Glucagon
Secreted by the alpha cells in response to decreasing concentrations of glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pancreas

exocrine function

A

Digestive enzymes
Secreted by acinar cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

DM

general

A

Affects ~34.2 million (10.5%) people in the United States
Seventh-leadingcause of death (79,000 deaths annually)

Chronic condition characterized by disordered metabolism and inappropriate hyperglycemia due to:
Deficiency in insulin production or
Resistance to insulin’s action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

DM

uncontrolled disease leads to

A

blindness, limb amputation, kidney failure, and vascular and heart disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

DM

types(4)

A

Type I diabetes mellitus
5-10% of cases

Type II diabetes mellitus
~90% of cases

Gestational diabetes mellitus (5-7% of pregnancies)

Secondary diabetes
Drug- or chemical-induced diabetes (glucocorticoids use)
Complications of other diseases affecting the pancreas (pancreatitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Diabetes Mellitus – Type I

general and autoimmune process

A

Results from T-cell immune-mediated destruction of insulin-producing pancreatic islet cells over months to years → complete lack of insulin

Autoimmune process (95%)
Glutamic acid decarboxylase (GAD) antibodies - most common in adults
Insulin autoantibodies (IAA) – most common in children
Idiopathic (5%)

dont need to know antibodies just that you need 2 or more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

DM I

Age of incidence

A

Commonly arises in children and young adult
Most commonly diagnosed at ages 4–6 years, with 2nd peak in early teenage years
Incidence and prevalence are increasing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DM I

susceptibility

A

Gene mutation: HLA-linked (HLA-DQ, HLA-DR3, andHLA-DR4)

Associated with other autoimmune conditions

Environmental factors: drugs and chemical toxins, viral infections, dietary factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DM I

Patho
Stage 1

A

Asymptomatic
Characterized by normal fasting glucose, normal glucose tolerance, and the presence of ≥ 2 pancreatic autoantibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DM I

Pathi
Stage 3

A

Evidence of diabetes, defined by hyperglycemia with clinical symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

DM I

Patho
Stage 2

A

Asymptomatic
Characterized by pancreatic autoantibodies (usually multiple)
Dysglycemia: impaired fasting glucose, impaired glucose tolerance, or an abnormal HbA1c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

DM I

Clin Man

A

Characteristic symptoms of hyperosmolality (increase glucose in the bloodstream) and hyperketonemia (lipolysis)
Polyuria
Polydipsia
Polyphagia
Fatigue
Blurry vision
Weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

DM I

DKA

A

May present urgently with diabetic ketoacidosis (DKA) – 1/3 of pediatric patients
Usually precipitated by a “tipping” event (viral illness, trauma, emotional stress)
Abdominal pain
Vomiting
Fruity “acetone” breath

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DM I

Urinalysis

A

Glucosuria, ketonuria, microalbuminuria(sign of kidney damage, hopefully dont see)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DM I

Labs: insulin, random glucose, anything else?

A

↓ Serum insulin level

Random plasma glucose
≥200 mg/dL with symptoms of hyperglycemia → diabetes

Diabetes-related autoantibodies

13
Q

DM I

Fasting plasma glucose (FPG)

A

No calorie intake for at least 8 hours
≥126 mg/dL on more than 1 occasion → diabetes
100-125 mg/dL → impaired fasting glucose tolerance (↑ risk for diabetes/ prediabetes)

14
Q

DM I

2-hour plasma glucose during a 75-gram oral glucose tolerance test (OGTT)

A

≥200 mg/dL → diabetes

15
Q

DM I

hemoglobin A1C

A

Indirect measure of average blood glucose levels over an 8-12 weeks

Multiple factors can affect A1C levels: age, race, genetic background, recent blood transfusion, chronic alcohol use, RBS disorders, chronic liver disease

≥ 6.5% → diabetes

not as reliable, especially if someone is presenting with DKA

better for monitoring

16
Q

DM I

Measure C-peptide

A

Measured in blood or urine (24-hour collection)
Released from the pancreas with insulin production

Indicates how much insulin is being made by the body
Low levels indicate insulin deficiency (type 1 DM)
High levels indicateinsulin resistance (type 2DM)

when you produce insulin you also produce C peptide

17
Q

DM I

Diabetes education

A

initially and then on a yearly basis

How to monitor glucose levels
Fasting
Near meals (before and/or after)
With signs and symptoms ofhypoglycemiaor hyperglycemia
How to administer insulin
Signs of disease progression
Beneficial lifestyle changes

18
Q

DM I

Beneficial lifestyle modifications

A

Nutritional and dietary requirements (dietitian)
Instruction on carbohydrate counting and insulin –to-carbohydrate ratio (1:15)
Regular exercise
Weight losswith reduced caloric intake if overweight or obese

Smoking cessation to decrease the risk of comorbid complications

(15 g of a carbohydrate = one carb serving; 1 unit of insulin for 1 carb serving)

19
Q

DM I

Tx

A

No cure for diabetes

Insulin replacement required for the treatment of type 1 DM
Comes in multiple preparations: rapid-acting, short-acting, and long-acting
Administered by subcutaneous injection or by infusion pump

should have glucagon for if glucose is too low

20
Q

DM I

Self-monitoring or continuous glucose monitoring

A

Increasing use of continuous glucose monitoring systems (DexCom)
Measures glucose concentrations continuously in the interstitial fluid for 7-14 days
Glucose data can be transmitted to a smartphone or to the screen of an insulin pump
Directional arrows indicate the rate and direction of change of glucose levels
Alerts can be set for dangerously low or high glucose values

21
Q

DM I

initial dose of insulin

A

Total daily dose of 0.2–0.6 units/kg/day; some people may require up to 0.7 units/kg/day

May need increased dosing for:
Adolescents duringpuberty
Individuals withinfectionsor other acute medical conditions
Acute stress situations

Starting dose can be adjusted up or down every few days based on bloodglucose

22
Q

DM I

Administration → basal + bolusinsulin

A

Basalinsulin (40-50% of total daily insulin dose)
↓ Hepaticglucoseproduction
Helps achieve normoglycemia in thefasting state
Long-actinginsulin

Bolusinsulin
Prandial (pre-meal)insulincovers theglucoseincrease after food intake
Short- or rapid-actinginsulin

23
Q

Rapid-acting insulin

A

Start working in 12–30 minutes, peaks in 1-3 hours
Glulisine(Apidra)
Lispro(Humalog)
Aspart (NovoLog)

24
Q

Short-actinginsulin:

A

Starts working in 30-60 minutes, peaks at 2-4 hours
Rapid-acting and short-acting insulins are used in combination with longer-acting insulins or ininsulin pumps fortype 1 diabetes

25
Q

Long-actinginsulin

A

Starts working in 2-4 hours, duration of action 17–24 hours
Glargine (Lantus)
Detemir (Levemir)

26
Q

DM I

Dawn Phenomenon

A

In the early morning hours, hormones (growth hormone, cortisol, and catecholamines) cause the liver to release large amounts of glucose into the bloodstream

In diabetic patients, the body does not produce enough insulin causing high blood sugar in the morning (before eating)

If the blood sugar level is normal or high at 2 a.m. to 3 a.m., it is likely the dawn phenomenon

Avoid carbohydrate snacks late in the evening

27
Q

DM I

Somogyi Effect

A

If the blood sugar level drops too low in the early morning hours, hormones (growth hormone, cortisol, and catecholamines) are released to reverse the low blood sugar level

In diabetic patients who takes insulin and do not eat a bedtime snack their blood sugar level can drop during the night and the body will releasing hormones that raise the blood sugar level causing hyperglycemia

If the blood sugar level is low at 2 a.m. to 3 a.m., suspect the Somogyi effect

28
Q
A
29
Q

DM I

Clinician monitoring

A

Regularweight and BP checks at each follow-up visit

Lab testing of HbA1clevels to evaluateglucosecontrol and efficacy of therapy - Target goal: < 7%
Every 6 months if HbA1cis at target goal
Every 3 months if HbA1cis above target goal

Annual microalbumin:creatinine ratio urine test
Start an ACE inhibitor for patients with albuminuria to protect kidneys

Lipid testing annually:
Triglycerides, totalcholesterol, HDL, and LDL with goal < 100 mg/dL

Annual eye exam
Annual foot exam
Prophylactic vaccines (influenza, pneumococcal)
Regular dental exams

30
Q

DM I

Complications

acute/chronic

A

Acute
Hypoglycemia
Hyperglycemia, including diabetic ketoacidosis

Chronic
Nephropathy
Neuropathy
Retinopathy
Coronary artery disease
Peripheral arterial disease
CVA/TIA
Diabetic foot disease (foot ulcers and amputations)

31
Q
A

CMT-dos (95 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions